Evidence map›Paper›PMID 26312436›Full record

ArticleACS applied materials & interfaces2015

Triggerable Degradation of Polyurethanes for Tissue Engineering Applications.

Cancan Xu, Yihui Huang, Jinglei Wu, Liping Tang, Yi Hong

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Glutathione-responsive biodegradable polyurethane nanoparticles for lung cancer treatment.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cancan XuDepartment of Bioengineering, University of Texas at Arlington , Arlington, Texas 76019, United States.
Yihui HuangDepartment of Bioengineering, University of Texas at Arlington , Arlington, Texas 76019, United States.
Jinglei WuDepartment of Bioengineering, University of Texas at Arlington , Arlington, Texas 76019, United States.
Liping TangDepartment of Bioengineering, University of Texas at Arlington , Arlington, Texas 76019, United States.
Yi HongDepartment of Bioengineering, University of Texas at Arlington , Arlington, Texas 76019, United States.
The University of Texas Southwestern Medical Center · USThe University of Texas at Arlington · US

Funding

American Heart Association-American Stroke Association 14BGIA20510066
6 · The paper itself

Abstract

Tissue engineered and bioactive scaffolds with different degradation rates are required for the regeneration of diverse tissues/organs. To optimize tissue regeneration in different tissues, it is desirable that the degradation rate of scaffolds can be manipulated to comply with various stages of tissue regeneration. Unfortunately, the degradation of most degradable polymers relies solely on passive controlled degradation mechanisms. To overcome this challenge, we report a new family of reduction-sensitive biodegradable elastomeric polyurethanes containing various amounts of disulfide bonds (PU-SS), in which degradation can be initiated and accelerated with the supplement of a biological product: antioxidant-glutathione (GSH). The polyurethanes can be processed into films and electrospun fibrous scaffolds. Synthesized materials exhibited robust mechanical properties and high elasticity. Accelerated degradation of the materials was observed in the presence of GSH, and the rate of such degradation depends on the amount of disulfide present in the polymer backbone. The polymers and their degradation products exhibited no apparent cell toxicity while the electrospun scaffolds supported fibroblast growth in vitro. The in vivo subcutaneous implantation model showed that the polymers prompt minimal inflammatory responses, and as anticipated, the polymer with the higher disulfide bond amount had faster degradation in vivo. This new family of polyurethanes offers tremendous potential for directed scaffold degradation to promote maximal tissue regeneration.

Indexed as

Tissue Engineering3T3 CellsAnimalsBiocompatible MaterialsCell ProliferationCell SurvivalDisulfidesFemaleGlutathioneInjections, SubcutaneousMiceMice, Inbred BALB CPolyurethanesProstheses and ImplantsTissue ScaffoldsBiocompatible MaterialsDisulfidesGlutathionePolyurethanesbiodegradationpolyurethanereduction-sensitivescaffoldstissue engineeringtriggerable

Identifiers

PMID26312436
PMCPMC10965041
OpenAlexW2395515284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.